922 related articles for article (PubMed ID: 35409008)
1. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
Ting CT; Chen BS
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
[TBL] [Abstract][Full Text] [Related]
2. Genetic and Epigenetic Host-Virus Network to Investigate Pathogenesis and Identify Biomarkers for Drug Repurposing of Human Respiratory Syncytial Virus via Real-World Two-Side RNA-Seq Data: Systems Biology and Deep-Learning Approach.
Hsu BW; Chen BS
Biomedicines; 2023 May; 11(6):. PubMed ID: 37371627
[TBL] [Abstract][Full Text] [Related]
3. Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications.
Lin YC; Chen BS
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142321
[TBL] [Abstract][Full Text] [Related]
4. Drug Target Identification and Drug Repurposing in Psoriasis through Systems Biology Approach, DNN-Based DTI Model and Genome-Wide Microarray Data.
Zhan YP; Chen BS
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373186
[TBL] [Abstract][Full Text] [Related]
5. Systems Drug Design for Muscle Invasive Bladder Cancer and Advanced Bladder Cancer by Genome-Wide Microarray Data and Deep Learning Method with Drug Design Specifications.
Su PW; Chen BS
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430344
[TBL] [Abstract][Full Text] [Related]
6. Systems Approach to Pathogenic Mechanism of Type 2 Diabetes and Drug Discovery Design Based on Deep Learning and Drug Design Specifications.
Chang S; Chen JY; Chuang YJ; Chen BS
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375269
[TBL] [Abstract][Full Text] [Related]
7. Investigating Core Signaling Pathways of Hepatitis B Virus Pathogenesis for Biomarkers Identification and Drug Discovery via Systems Biology and Deep Learning Method.
Chang S; Wang LH; Chen BS
Biomedicines; 2020 Aug; 8(9):. PubMed ID: 32878239
[TBL] [Abstract][Full Text] [Related]
8. Integrated Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer Patients.
Chen Y; Qin Y; Fu Y; Gao Z; Deng Y
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555339
[TBL] [Abstract][Full Text] [Related]
9. COVID-19-Associated acute respiratory distress syndrome (CARDS): Mechanistic insights on therapeutic intervention and emerging trends.
Thapa K; Verma N; Singh TG; Kaur Grewal A; Kanojia N; Rani L
Int Immunopharmacol; 2021 Dec; 101(Pt A):108328. PubMed ID: 34768236
[TBL] [Abstract][Full Text] [Related]
10. Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19: a critical discussion of recent publications.
Garrido-Mesa J; Adams K; Galvez J; Garrido-Mesa N
Expert Opin Investig Drugs; 2022 May; 31(5):475-482. PubMed ID: 35294307
[TBL] [Abstract][Full Text] [Related]
11. Multiple-Molecule Drug Design Based on Systems Biology Approaches and Deep Neural Network to Mitigate Human Skin Aging.
Yeh SJ; Lin JF; Chen BS
Molecules; 2021 May; 26(11):. PubMed ID: 34073305
[TBL] [Abstract][Full Text] [Related]
12. A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19.
Sahebnasagh A; Mojtahedzadeh M; Najmeddin F; Najafi A; Safdari M; Rezai Ghaleno H; Habtemariam S; Berindan-Neagoe I; Nabavi SM
Arch Med Res; 2020 Oct; 51(7):631-635. PubMed ID: 32863034
[TBL] [Abstract][Full Text] [Related]
13. Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis.
Gando S; Wada T
Shock; 2022 Jan; 57(1):1-6. PubMed ID: 34172612
[TBL] [Abstract][Full Text] [Related]
14. Repurposing of drugs targeting the cytokine storm induced by SARS-CoV-2.
Ng WH; Tang PCH; Mahalingam S; Liu X
Br J Pharmacol; 2023 Jan; 180(2):133-143. PubMed ID: 36394425
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Review of Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome.
Khiali S; Khani E; Entezari-Maleki T
J Clin Pharmacol; 2020 Sep; 60(9):1131-1146. PubMed ID: 32557541
[TBL] [Abstract][Full Text] [Related]
16. Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis.
MotieGhader H; Safavi E; Rezapour A; Amoodizaj FF; Iranifam RA
Sci Rep; 2021 Nov; 11(1):21872. PubMed ID: 34750486
[TBL] [Abstract][Full Text] [Related]
17. A Case Report for Using Methylprednisolone for Severe ARDS Caused by SARS-CoV-2 Delta Variant in a Pediatric Patient With Lennox-Gastaut Syndrome.
Park E; You J
J Korean Med Sci; 2022 Mar; 37(10):e82. PubMed ID: 35289141
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms revealed by network pharmacology of Xuebijing on the treatment of acute respiratory distress syndrome caused by novel coronavirus infection.
Tao P; Jiming L
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(8):2651-2661. PubMed ID: 35503609
[TBL] [Abstract][Full Text] [Related]
19. COVID-19: Discovery, diagnostics and drug development.
Asselah T; Durantel D; Pasmant E; Lau G; Schinazi RF
J Hepatol; 2021 Jan; 74(1):168-184. PubMed ID: 33038433
[TBL] [Abstract][Full Text] [Related]
20. Repurposing Fostamatinib to Combat SARS-CoV-2-Induced Acute Lung Injury.
Tabassum N; Zhang H; Stebbing J
Cell Rep Med; 2020 Nov; 1(8):100145. PubMed ID: 33225317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
